BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6026525)

  • 1. Mechanisms of action of diazoxide.
    Blackard WG; Aprill CN
    J Lab Clin Med; 1967 Jun; 69(6):960-7. PubMed ID: 6026525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of the metabolic and circulatory (cardiovascular) effects of diazoxide through alpha--and beta-receptor blockade].
    Börner E; Biro G; Kettl H; Weinges KF
    Horm Metab Res; 1969 Nov; 1(6):296-300. PubMed ID: 4401003
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenergic receptor mediation of renin secretion.
    Winer N; Chokshi DS; Yoon MS; Freedman AD
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1168-75. PubMed ID: 4390114
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenergic beta receptors and plasma free fatty acids.
    Zsoter T; Tom H; Kraml M; Dvornik D
    J Pharmacol Exp Ther; 1966 Jun; 152(3):425-31. PubMed ID: 4380725
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-adrenergic inhibition of immunoreactive insulin release during deep hypothermia.
    Baum D; Porte D
    Am J Physiol; 1971 Jul; 221(1):303-11. PubMed ID: 4397536
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute metabolic studies with trasicor in diabetics.
    McKechnie JK; Goldman A; Vinik AI
    S Afr Med J; 1969 Dec; ():Suppl:24-6. PubMed ID: 4906673
    [No Abstract]   [Full Text] [Related]  

  • 7. The antagonism of phentolamine against exogenously administered and endogenously released norepinephrine in rabbit aortic strips.
    Urquilla PR; Stitzel RE; Fleming WW
    J Pharmacol Exp Ther; 1970 Apr; 172(2):310-9. PubMed ID: 4315002
    [No Abstract]   [Full Text] [Related]  

  • 8. Agonist-antagonist interactions in the normal and supersensitive nictitating membrane of the spinal cat.
    Green RD; Fleming WW
    J Pharmacol Exp Ther; 1967 May; 156(2):207-14. PubMed ID: 6026252
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenergic receptors of the bovine iris sphincter.
    Patil PN
    J Pharmacol Exp Ther; 1969 Apr; 166(2):299-307. PubMed ID: 5776988
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the adrenergic receptor blocking properties of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl and propranolol.
    Levy B
    J Pharmacol Exp Ther; 1967 Jun; 156(3):452-62. PubMed ID: 6067476
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of diazoxide on golden hamsters with chronic hypoglycemia due to a transplantable islet-cell tumor.
    Lefebvre P; Luyckx A; Cession-Fossion A
    Horm Metab Res; 1972 Sep; 4(5):355-60. PubMed ID: 4345752
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the sensitivity to catecholamines after thyroidectomy.
    Bray GA
    Endocrinology; 1966 Sep; 79(3):554-64. PubMed ID: 5922925
    [No Abstract]   [Full Text] [Related]  

  • 13. Some pharmacological properties of a new beta-adrenergic blocking agent, 1-(isopropylamino)-3-(o-phenoxyphenoxy)-2-propanol, HCl (Ph QA 33).
    Hermansen K
    Acta Pharmacol Toxicol (Copenh); 1968; 26(4):343-62. PubMed ID: 5755482
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the mechanism of antihypertensive action of diazoxide: in vitro vascular pharmacodynamics.
    Wohl AJ; Hausler LM; Roth FE
    J Pharmacol Exp Ther; 1967 Dec; 158(3):531-9. PubMed ID: 6073233
    [No Abstract]   [Full Text] [Related]  

  • 15. A receptor mechanism for the inhibition of insulin release by epinephrine in man.
    Porte D
    J Clin Invest; 1967 Jan; 46(1):86-94. PubMed ID: 6018752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of the drinking response to some hypotensive drugs: activation of the renin-angiotensin system by direct or reflex-mediated stimulation of -receptors.
    Meyer DK; Rauscher W; Peskar B; Hertting G
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(1):13-24. PubMed ID: 4347991
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist.
    Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1969 May; 167(1):117-42. PubMed ID: 5772742
    [No Abstract]   [Full Text] [Related]  

  • 18. [Spasmolytic effect of beta-adrenergic drugs. Conservative treatment of urolithiasis].
    Melchior H; Lymberopoulos S; Lutzeyer W
    Urologe; 1971 Jul; 10(4):183-8. PubMed ID: 4397818
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of reserpine and propranolol on the therapeutic and toxic effects of peruvoside in the heart-lung preparation and intact dogs.
    Arora RB; Bagchi N; Gupta OP
    Indian J Med Res; 1972 Jan; 60(1):143-52. PubMed ID: 5029118
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of reserpine, phentolamine and propranolol on some parameters of the kininogen system in the plasma of rats fed on a high salted diet (author's transl)].
    Szurska G
    Ann Univ Mariae Curie Sklodowska Med; 1976; 31():169-74. PubMed ID: 1032774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.